96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulin
#2402Thionin-D4E1 chimeric protein protects plants against bacterial infections
#2403RECOMBINANT FACTOR VIII PROTEINS
#2404Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#2405Promiscuous HPV16-derived T helper epitopes for immunotherapy
#2406Peptide domains that bind small molecules of industrial significance
#2407PTEN antagonist peptides and methods of using the same
#2408Peptide compounds to regulate the complement system
#2409Immune system modulators
#2410Cell transport
#2411Specific peptide binders to proteins identified via systematic discovery, maturation and extension process
#2412Lipopolysaccharide-targeted peptide mimic vaccine against Q fever
#2413Triazole macrocycle systems
#2414Peptide inhibitors of BACE1
#2415Cell penetrating protein adaptor molecules and their application in research and medicine
#2416NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR
#2417COMPOUNDS AND COMPOSITIONS FOR IMAGING GCC-EXPRESSING CELLS
#2418Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines
#2419Polypeptide, nucleotide sequence thereof, and method for using the same for preventing DNA synthesis and inhibiting cell proliferation
#2420Polypeptide-based shuttle agents for improving the transduction efficiency of polypeptide cargos to the cytosol of target eukaryotic cells, uses thereof, methods and kits relating to same
#2421Composition and method for therapeutic agent delivery during pregnancy
#2422Dpy-30 binding peptides and methods of use
#2423Elicitor peptides having disrupted hypersensitive response box and use thereof
#2424Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
#2425Antimicrobial peptides and methods of use thereof
#2426Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
#2427SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES
#2428Triazole macrocycle systems
#2429Methods, Peptides and Antibodies for Preventing, Treating and Diagnosing an Inflammatory Condition
#2430Light-sensitive ion-passing molecules
#2431VASCULAR EMBOLIC SYSTEM
#2432Methods of treating cancers with peptide-based modulators
#2433Mass spectrometric assays for peptides
#2434Activation of bioluminescence by structural complementation
#2435Antisense composition and method for treating muscle atrophy
#2436Biologically active proteins having increased in vivo and/or in vitro stability
#2437Natural IGM antibodies and inhibitors thereof
#2438proteins, nucleic acids, and methods of their use
#2439Immunomodulators
#2440Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#2441Peptide inhibitors of TEAD/YAP-TAZ interaction
#2442Methods of using myelin basis protein peptide compositions
#2443Bioactive peptides having insecticide activity
#2444Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
#2445IMMUNOGENIC PEPTIDES OF THE CYCLIN B1 TUMOR ANTIGEN
#2446Peptide inhibitor of HIV reverse transcription
#2447Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 protein
#2448Cell-penetrating peptides
#2449Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#2450Method for removing genomically unstable IPS cells and synthetic peptide used therefor
#2451MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#2452Immunoregulatory peptides and methods of use
#2453Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#2454Peptidomimetic macrocycles
#2455AB Modulating Peptides
#2456Methods and compositions based on Shiga toxin type 2 protein
#2457Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#2458Anti-CTLA4 antibody-TGF-βRII targeted/immunomodulatory fusion proteins
#2459Mitochondrial targeting and therapeutic use thereof
#2460POLYOMAVIRUS PEPTIDE SEQUENCES
#2461c-Met protein agonist
#2462Connective tissue stimulating peptides
#2463Composition comprising a mixture of CD95-Fc isoforms
#2464COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION
#2465ALPHA HELIX CELL-PENETRATING PEPTIDE MULTIMER, PREPARATION METHOD THEREFOR AND USE THEREFOR
#2466Cyclic peptide conjugates and methods of use
#2467Lipidated peptides for lowering blood glucose
#2468Anti-EGFR activatable antibodies
#2469Targeting the EGFR-SGLT1 interaction for cancer therapy
#2470ASSAY FOR DETERMINING RELATIVE REDOX CHANGES IN LIVING CELLS AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS
#2471Nuclear targeting sequences
#2472VIP fragments and methods of use
#2473Polypeptide ligands specific for plasma kallikrein
#2474Selective delivery molecules and methods of use
#2475Cell-penetrating compstatin analogs and uses thereof
#2476Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#2477Peptides capable of reactivating p53 mutants
#2478Ph-sensitive peptides and their nanoparticles for drug delivery
#2479PLIF multimeric peptides and uses thereof
#2480Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2481Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#2482Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2483Macrocyclic peptide, method for producing same, and screening method using macrocyclic peptide library
#2484MSIA-SRM ASSAY FOR BIOMARKER ANALYSIS
#2485Peptides inhibiting cold-inducible RNA binding protein activity
#2486Methods and compositions for treatment of cartilage and disc tissue pathologies
#2487Ligands to radiation-induced molecules
#2488Protein drug formulations and packages
#2489Insulin independence among patients with diabetes utilizing an optimized hamster Reg3 gamma peptide
#2490Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#2491Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#2492Glycogen synthase kinase-3 inhibitors
#2493Peptides and peptide/active compound conjugates for renal targeting
#2494Development of novel macromolecule transduction domain with improved cell permeability and method for using same
#2495CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#2496NPR-B agonists
#2497Mineralizing biosurfactant used for nucleating silica
#2498PEPTIDES SHARED AMONG LETHAL CANCERS AND THERAPEUTIC COMPOSITIONS COMPRISING SAID PEPTIDES
#2499Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
#2500MAP kinase P38 binding compounds
#2501Methods and compositions for the treatment of axonal and neuronal degeneration
#2502SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING
#2503Peptides
#2504Cortistatin analogues for the treatment of inflammatory and/or immune diseases
#2505Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES
#2506Protransduzin B, a gene transfer enhancer
#2507Butyrylcholinesterase zwitterionic polymer conjugates
#2508Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
#2509Compositions for and methods of treating and preventing targeting tumor associated carbohydrate antigens
#2510Immunomodulators
#2511Peptide for suppressing osteoclast differentiation and use thereof
#2512PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
#2513Coupling method for peptide synthesis at elevated temperatures
#2514Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
#2515IL-13 receptor binding peptides
#2516Melanotropin ligands for skin care
#2517Detection of degradative enzymes and biomolecules in bodily fluids
#2518Method of treating cancer with an EGFR targeted immunomodulatory fusion protein
#2519Methods and compositions for the treatment of gastrointestinal disorders
#2520IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
#2521TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE
#2522SIGNAL SEQUENCE FOR PROTEIN EXPRESSION IN PICHIA PASTORIS
#2523CD200 inhibitors and methods of use thereof
#2524BIOCONJUGATES OF SYNTHETIC APELIN POLYPEPTIDES
#2525Antibody targeting through a modular recognition domain
#2526A4B7 peptide monomer and dimer antagonists
#2527APJ Receptor Compounds
#2528Therapeutic agents for reducing parathyroid hormone levels
#2529Protease-resistant peptide ligands
#2530Affinity tags and processes for purifying and immobilizing proteins using same
#2531Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#2532METHODS OF PREPARATION AND COMPOSITION OF PEPTIDE CONSTRUCTS USEFUL FOR TREATMENT OF RHEUMATOID ARTHRITIS
#2533Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
#2534Polymer conjugates of protegrin peptides
#2535Dispersion and detachment of cell aggregates
#2536OLIGOPEPTIDE SPECIFIC TO COLORECTAL CANCER CELL AND APPLICATION THEREOF
#2537Mycobacterium antigens
#2538Peptide linkers for polypeptide compositions and methods for using same
#2539Compositions and methods of treatment of cancers
#2540α4β7 peptide monomer and dimer antagonists
#2541Anti-microbial peptides and methods of use thereof
#2542Cell-penetrating peptide, conjugate comprising same and composition comprising same
#2543Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins
#2544PEPTIDE-PRESENTING PROTEIN AND PEPTIDE LIBRARY USING SAME
#2545Hypersensitive response elicitor peptides and use thereof
#2546Disulfide cyclic polypeptides for the treatment of heart failure
#2547Compositions and methods for targeted endometriosis treatment
#2548Ultra-pure agonists of guanylate cyclase C, method of making and using same
#2549Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#2550Strong Secretory Signal Peptide Enhancing Small Peptide Motifs and the Use Thereof
#2551Cell penetrating peptides for intracellular delivery of molecules
#2552SUPPRESSION OF ITCH
#2553Biosynthetic proline/alanine random coil polypeptides and their uses
#2554Polynucleotide encoding a fusion protein for improving skin conditions
#2555Immunomodulators
#2556Method of modulating sex hormone levels using a sex hormone secretion modulator
#2557Peptide and Complex of Same, Scaffold for Tissue Repair and Surface Treatment Method for Same, and Surface Treatment Solution or Set of Treatment Solutions
#2558BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#2559Immunity to folate receptors
#2560T CELL EPITOPES DERIVED FROM ALT A 1 OR ALT A 5 FOR THE TREATMENT OF ALTERNARIA ALTERNATA ALLERGY
#2561GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
#2562Compositions and methods for specific regulation of pyruvate dehydrogenase kinase
#2563Methods and compositions for the treatment of cancer
#2564Agents for preventing and treating HIV and other viral infections
#2565REPLIKIN-BASED COMPOUNDS FOR PREVENTION AND TREATMENT OF INFLUENZA AND METHODS OF DIFFERENTIATING INFECTIVITY AND LETHALITY IN INFLUENZA
#2566FC receptor (FcRn) binding peptides and uses thereof
#2567Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases
#2568Peptides with antagonistic activities against natural CXCR4
#2569Conotoxin peptides, pharmaceutical compositions and uses thereof
#2570Peptide Ligation
#2571Cell-penetrating drug carrier and the application thereof
#2572Inhibitors of mitochondrial fission and methods of use thereof
#2573Immunologically active polypeptide
#2574Peptides binding to parallel-stranded G-quadruplexes
#2575Cell penetrating peptides for intracellular delivery of molecules
#2576PAN-DR binding polypeptides and uses thereof
#2577Selectin inhibitors, composition, and uses related thereto
#2578Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain
#2579Anti-angiogenic molecules, nanostructures and uses thereof
#2580Therapeutics for the induction of endogenous steroidogenesis and methods associated with their identification
#2581Compositions and methods relating to ionic salts of peptides
#2582Immunomodulators
#2583Peptide Inhibitors of Sodium Channels
#2584Peptides having anti-inflammatory properties
#2585Peptide with anti-aging effect and use thereof
#2586Antimicrobial Enzyme Fusions Reduce Resistance and Kill Intracellular Staphylococcus aureus
#2587CONJUGATES COMPRISING MANNAN AND MYELIN BASIC PROTEIN (MBP)
#2588Elicitor peptides having disrupted hypersensitive response box and use thereof
#2589Hypersensitive response elicitor peptides and use thereof
#2590Self-assembling peptide cages from coiled-coil peptide modules
#2591Cell penetrating peptides for intracellular delivery of molecules
#2592Self-assembled peptide nanostructures by exploiting conformational change, biosensor using the same and detection method of biomolecules using the same
#2593Development of Protein-Based Biotherapeutics That Penetrate Cell-Membrane and Induce Anti-Cancer Effect - Cell-Permeable Trefoil Factor 1 (CP-TFF1) in Gastrointestinal Track (GIT) Cancer, Polynucleotides Encoding The Same, and Anti-Cancer Compositions Comprising The Same
#2594Peptide and peptidomimetic inhibitors
#2595COMPOSITIONS AND METHODS FOR ENDOTOXIN NEUTRALIZATION
#2596Inhibitors of the Eph-A receptor and uses thereof
#2597Cyclic cationic peptides with antimicrobial activity
#2598COMPOSITIONS AND METHODS FOR TARGETING ANTIGEN-PRESENTING CELLS
#2599Activatable membrane-interacting peptides and methods of use
#2600Aquaporin-4 Peptide Compositions and Methods of Use
#2601Peptide for inducing mast cell-specific apoptosis and use thereof
#2602Synthetic anti-inflammatory peptides and use thereof
#2603Method for promoting hair growth
#2604Inhibitors of proteins specific for the secretome of a chondrocyte for use in the treatment of breast cancer metastasis
#2605POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE
#2606Modified proteins and methods of use thereof
#2607PEPTIDOMIMETIC MACROCYCLES
#2608Stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy
#2609THERAPEUTIC AGENT FOR CARDIAC TAMPONADE
#2610Anti-tumor polypeptides and method for preparing anti-tumor drugs comprisng the same
#2611Bone substitute nanocomposites and methods of synthesis using multiphosphorylated peptides
#2612APJ RECEPTOR AGONISTS AND USES THEREOF
#2613Identification and characterization of a peptide affinity reagent for the detection of noroviruses in clinical samples
#2614DNA aptamers binding the histidine tag and their application
#2615Therapeutic DLL4 binding proteins
#2616Development of Protein-Based Biotherapeutics That Induced Osteogenesis for Bone Healing Therapy: Cell-Permeable BMP2 and BMP7 Recombinant Proteins (CP-BMP2 & CP-BMP7), Polynucleotides Encoding the Same and Pro-osteogenic Compositions Comprising the Same
#2617Development of a Protein-Based Biotherapeutic Agent That Penetrates Cell-Membrane and Induces Anti-Tumor Effect in Solid Tumors - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Tumor Compositions Comprising the Same
#2618Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Angiogenic Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Angiogenic Compositions Comprising the Same
#2619Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Pancreatic Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Pancreatic Cancer Compositions Comprising the Same
#2620Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Lung Cancer Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Lung Cancer Compositions Comprising the Same
#2621Development of Protein-Based Biotherapeutics That Penetrates Cell-Membrane and Induces Anti-Hepatocellular Carcinoma Effect - Improved Cell-Permeable Suppressor of Cytokine Signaling (iCP-SOCS3) Proteins, Polynucleotides Encoding the Same, and Anti-Hepatocellular Carcinoma Compositions Comprising the Same
#2622COMPSTATIN AND ANALOGS THEREOF FOR EYE DISORDERS
#2623Cell penetrating peptides for intracellular delivery of molecules
#2624Biologically active peptides
#2625Lipopeptides for delivery of nucleic acids
#2626Methods, uses and compositions of Tie2 agonists
#2627Methods and systems for designing and/or characterizing soluble lipidated ligand agents
#2628CRP40 FRAGMENTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#2629β-hairpin peptidomimetics
#2630Templates for controlling synthesis of nanoparticles into discrete assemblies
#2631Use of inhibitory peptides for the treatment of inflammatory diseases
#2632Immunogenic epitopes for immunotherapy
#2633Anti-angiogenic peptides and uses thereof
#2634Peptide analogs of alpha-melanocyte stimulating hormone
#2635EGFR-binding modular recognition domains
#2636Modulation of structured polypeptide specificity
#2637STAPLING eIF4E INTERACTING PEPTIDES
#2638Stabilized SOS1 peptides
#2639Targeting peptides and uses thereof
#2640Peptides for the treatment of cancer
#2641Peptide with gold binding and EGFR receptor affinity and same attached to gold nanostructure
#2642Inhibitors of TLR signaling by targeting TIR domain interfaces
#2643COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#2644INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE
#2645Insulin independence among patients with diabetes utilizing an optimized hamster REG3 gamma peptide
#2646REGULATING BACILLUS ANTHRACIS LETHAL FACTOR ACTIVITY VIA AN ACTIVATING EPITOPE REGION
#2647Peptides with antifungal activity and methods of using the peptides
#2648EIF4E binding peptides
#2649Methods for Selecting Peptides that Bind to Disease Specific Antibodies, Disease Specific Peptides and Uses Thereof
#2650Water buffalo derived dimeric peptide containing proline for antibiotic therapies
#2651Amyloidosis-inhibiting polypeptides and their use
#2652a4B7 integrin thioether peptide antagonists
#2653Compositions for preventing and/or treating an infection by an HIV-1 virus
#2654RHAMM binding peptides
#2655TARGETING PEPTIDES THAT BIND S. MUTANS, CONSTRUCTS COMPRISING SUCH PEPTIDES AND USES THEREOF
#2656Water buffalo derived peptide antibiotic therapies
#2657Triazole macrocycle systems
#2658COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS
#2659Methods for detecting peptide/MHC/TCR binding
#2660Polypeptides for treating and/or limiting influenza infection
#2661Biocompatible protein, biocompatible protein gel and biocompatible conducting protein gel comprising the protein and method for preparing the same
#2662Stapled and stitched polypeptides and uses thereof
#2663CD44V6-derived peptides for treating breast cancer
#2664Proteas stabilized antibacterial peptides for
#2665Vaccine
#2666Inhibitory peptides of viral infection
#2667HIGH-AFFINITY MATRIPTASE INHIBITORS
#2668Stem cell mobilization and tissue repair and regeneration
#2669ENDOLYSIN OBPGPLYS
#2670Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
#2671MODIFIED INGAP PEPTIDES FOR TREATING DIABETES
#2672NOVEL POLYPEPTIDES HAVING SATIETY HORMONE RELEASING ACTIVITY
#2673IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
#2674Compositions and methods for modulating gamma-C-cytokine activity
#2675Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
#2676Peptide additives for enhancing acceptance and ingestion of edibles by rodents and uses thereof
#2677Bovine fusion antibodies
#2678Polypeptides for treating and/or limiting influenza infection
#2679Peptides for the Treatment of Immune Reconstitution Inflammatory Syndrome (IRIS) and Related Diseases
#2680BRAIN TUMOR TARGETING PEPTIDES AND METHODS
#2681Peptide inhibitor of Nox1 NADPH oxidase
#2682RAPID TEST FOR CELLULAR FIBRONECTIN
#2683Mitochondria targeting peptide
#2684CRYSTALLINE FORM OF LINACLOTIDE
#2685Polypeptide specifically binding to rare earth nanoparticles and use thereof
#2686MEANS AND METHODS OF ENHANCING DELIVERY TO BIOLOGICAL SYSTEMS
#2687p53 activating peptides
#2688Pro-angiogenic fragments of prominin-1 and uses thereof
#2689Methods and compositions comprising a C-terminal Bax peptide
#2690Formulations of guanylate cyclase C agonists and methods of use
#2691Compositions and Methods of Analysis
#2692CDKACT BIOSENSORS-FLUORESCENT POLYPEPTIDE TO PROBE THE ACTIVITY OF CDK/CYCLIN KINASES IN VITRO, IN CELLULO AND IN VIVO
#2693Signal biomarkers
#2694Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#2695Antibody-binding peptide
#2696Peptidomimetic compounds
#2697Endometriosis cell targeting peptide and uses thereof
#2698Immunogenic WT-1 peptides and methods of use thereof
#2699USP30 INHIBITORS AND METHODS OF USE
#2700Extracellular histones as biomarkers for prognosis and molecular targets for therapy